Prometheus Laboratories

The Medicare contractor proposed coverage for several cancer assays, but would not cover molecular respiratory virus assays or a test for inflammatory bowel disease.

VANCOUVER, BC – At the American Society for Mass Spectrometry annual meeting here this week a number of major vendors reiterated their commitment to moving their instruments into the clinic (

Shares of Rosetta Genomics got a major boost this week after the company effected a one-for-fifteen reverse stock split, and then announced it had launched a new microRNA-based diagnostic and had obtained Medicare coverage for its flagship cancer of unknown primary origin microRN

The University of California of Oakland has received US Patent No. 8,162,555, "Printing pins having selective wettability and method of making same." Printing pins are described that have an exterior surface and an interior surface that defines a lumen or capillary tract.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The US Supreme Court today invalidated two patents held by Prometheus Laboratories in a widely watched case for those involved in the personalized medicine field.

Rosetta Genomics last week said that it has avoided bankruptcy by coming up with money owed to one-time partner Prometheus Laboratories.
Rosetta said that it has paid Prometheus $650,000, plus accrued and unpaid interest, on a promissory note that was due Nov. 22.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Rosetta Genomics disclosed after the close of the market on Thursday that it has paid $650,000 it owed to Prometheus Laboratories.

Pages

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.